1. Home
  2. MIRM vs AGM Comparison

MIRM vs AGM Comparison

Compare MIRM & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$65.07

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Federal Agricultural Mortgage Corporation

AGM

Federal Agricultural Mortgage Corporation

HOLD

Current Price

$182.33

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
AGM
Founded
2018
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
1.7B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MIRM
AGM
Price
$65.07
$182.33
Analyst Decision
Strong Buy
Buy
Analyst Count
11
1
Target Price
$87.55
$219.00
AVG Volume (30 Days)
545.4K
81.1K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
3.25%
EPS Growth
N/A
12.85
EPS
N/A
17.55
Revenue
$471,794,000.00
$377,946,000.00
Revenue This Year
$53.78
$14.80
Revenue Next Year
$19.91
$9.98
P/E Ratio
N/A
$10.52
Revenue Growth
53.66
8.81
52 Week Low
$36.88
$155.00
52 Week High
$78.55
$216.35

Technical Indicators

Market Signals
Indicator
MIRM
AGM
Relative Strength Index (RSI) 36.47 69.06
Support Level $63.66 $173.59
Resistance Level $66.77 $186.64
Average True Range (ATR) 2.99 4.35
MACD -0.66 1.31
Stochastic Oscillator 13.68 85.65

Price Performance

Historical Comparison
MIRM
AGM

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

Share on Social Networks: